Optimum designs for clinical trials in personalized medicine when response variance depends on treatment.

IF 1.2 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Belmiro P M Duarte, Anthony C Atkinson
{"title":"Optimum designs for clinical trials in personalized medicine when response variance depends on treatment.","authors":"Belmiro P M Duarte, Anthony C Atkinson","doi":"10.1080/10543406.2024.2395548","DOIUrl":null,"url":null,"abstract":"<p><p>We study optimal designs for clinical trials when the value of the response and its variance depend on treatment and covariates are included in the response model. Such designs are generalizations of Neyman allocation, commonly used in personalized medicine when external factors may have differing effects on the response depending on subgroups of patients. We develop theoretical results for D-, A-, E- and D<math><msub><mi> </mi><mrow><mrow><mi>A</mi></mrow></mrow></msub></math>-optimal designs and construct semidefinite programming (SDP) formulations that support their numerical computation. D-, A-, and E-optimal designs are appropriate for efficient estimation of distinct properties of the parameters of the response models. Our formulation allows finding optimal allocation schemes for a general number of treatments and of covariates. Finally, we study frequentist sequential clinical trial allocation within contexts where response parameters and their respective variances remain unknown. We illustrate, with a simulated example and with a redesigned clinical trial on the treatment of neuro-degenerative disease, that both theoretical and SDP results, derived under the assumption of known variances, converge asymptotically to allocations obtained through the sequential scheme. Procedures to use static and sequential allocation are proposed.</p>","PeriodicalId":54870,"journal":{"name":"Journal of Biopharmaceutical Statistics","volume":" ","pages":"1-18"},"PeriodicalIF":1.2000,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biopharmaceutical Statistics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10543406.2024.2395548","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

We study optimal designs for clinical trials when the value of the response and its variance depend on treatment and covariates are included in the response model. Such designs are generalizations of Neyman allocation, commonly used in personalized medicine when external factors may have differing effects on the response depending on subgroups of patients. We develop theoretical results for D-, A-, E- and D A-optimal designs and construct semidefinite programming (SDP) formulations that support their numerical computation. D-, A-, and E-optimal designs are appropriate for efficient estimation of distinct properties of the parameters of the response models. Our formulation allows finding optimal allocation schemes for a general number of treatments and of covariates. Finally, we study frequentist sequential clinical trial allocation within contexts where response parameters and their respective variances remain unknown. We illustrate, with a simulated example and with a redesigned clinical trial on the treatment of neuro-degenerative disease, that both theoretical and SDP results, derived under the assumption of known variances, converge asymptotically to allocations obtained through the sequential scheme. Procedures to use static and sequential allocation are proposed.

当反应差异取决于治疗方法时,个性化医疗临床试验的最佳设计。
我们研究了当反应值及其方差取决于治疗方法,且反应模型中包含协变量时临床试验的最佳设计。这种设计是奈曼分配的一般化,常用于外部因素可能因患者亚群的不同而对反应产生不同影响的个性化医疗中。我们提出了 D-、A-、E- 和 D A-最优设计的理论结果,并构建了支持其数值计算的半有限编程(SDP)公式。D-、A- 和 E-最优设计适用于有效估计响应模型参数的不同属性。我们的计算公式允许为一般数量的处理和协变量找到最优分配方案。最后,我们研究了在反应参数及其各自方差未知的情况下的频数主义序贯临床试验分配。我们通过一个模拟例子和一个重新设计的治疗神经退行性疾病的临床试验来说明,在已知方差的假设条件下得出的理论结果和 SDP 结果都会渐进地趋近于通过顺序方案得到的分配结果。提出了使用静态和顺序分配的程序。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Biopharmaceutical Statistics
Journal of Biopharmaceutical Statistics 医学-统计学与概率论
CiteScore
2.50
自引率
18.20%
发文量
71
审稿时长
6-12 weeks
期刊介绍: The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: Drug, device, and biological research and development; Drug screening and drug design; Assessment of pharmacological activity; Pharmaceutical formulation and scale-up; Preclinical safety assessment; Bioavailability, bioequivalence, and pharmacokinetics; Phase, I, II, and III clinical development including complex innovative designs; Premarket approval assessment of clinical safety; Postmarketing surveillance; Big data and artificial intelligence and applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信